Nosoh Y, Toge T, Niimi K, Nishiyama M, Hirabayashi N, Nakanishi K, Niimoto M, Hattori T
Jpn J Surg. 1987 May;17(3):168-73. doi: 10.1007/BF02470593.
The antitumor activities, resulting from the combined treatment of leukocyte interferon (IFN-alpha), with recombinant human immune interferon (IFN-gamma), against human tumor xenografts in nude mice, were studied. Nine human tumor xenografts, (7 from gastric carcinoma, 1 from gallbladder carcinoma and 1 from breast carcinoma), were serially transplanted into nude mice for the purpose of this experiment. Each human tumor xenograft was inoculated subcutaneously into BALB/c nu/nu nude mice and treatment was started after the estimated tumor had reached 100-300 mg. IFN was administered intramuscularly at a schedule of qd X 14. Treatment with either IFN-alpha or IFN-gamma alone, did not produce any antitumor effect against the various human tumor xenografts, however the combination of IFN-alpha with IFN-gamma resulted in achieving significant antitumor effects against the various human tumors. Inhibition of tumor growth was observed in 7 of the 9 tumors (77.8 per cent), and regression of the tumor was noted in 5 of the 9 tumors (55.6 per cent).
研究了白细胞干扰素(IFN-α)与重组人免疫干扰素(IFN-γ)联合治疗对裸鼠人肿瘤异种移植瘤的抗肿瘤活性。为进行本实验,将9种人肿瘤异种移植瘤(7种来自胃癌,1种来自胆囊癌,1种来自乳腺癌)连续移植到裸鼠体内。将每个人肿瘤异种移植瘤皮下接种到BALB/c nu/nu裸鼠中,在估计肿瘤达到100 - 300 mg后开始治疗。IFN按每日1次,共14天的方案肌肉注射。单独使用IFN-α或IFN-γ治疗,对各种人肿瘤异种移植瘤均未产生任何抗肿瘤作用,然而IFN-α与IFN-γ联合使用对各种人肿瘤产生了显著的抗肿瘤作用。在9个肿瘤中有7个(77.8%)观察到肿瘤生长受到抑制,9个肿瘤中有5个(55.6%)出现肿瘤消退。